In this episode of To The Point, RSTV Speaks to Adar Poonawalla, CEO and Owner, Serum Institute of India. As the world races to find a cure for the deadly novel coronavirus, Vaccine major Serum Institute of India plans to start production of the COVID-19 vaccine developed by Oxford University in the next few weeks. Speaking exclusively to Rajya Sabha TV, Adar Poonawalla, CEO, Serum Institute of India said that Government has removed the regulatory hurdles for development of vaccine.
For further information visit - RStv
New supply agreement between UNICEF and Serum Institute of India makes pneumococcal conjugate vaccine available at US$2.00 per dose, a 43 % reduction from the Gavi price at the start of the Advance Market Commitment
Serum Institute confident of manufacturing Covid vaccine’s 100 million doses if trials establish efficacy
Serum Institute’s Journey To Success | ET NOW Covid-19 vaccine possible by Q2 of 2022: Adar Poonawalla
Adar Poonawalla discusses Serum Institute's progress in the global battle against COVID-19 with Shereen Bhan, CNBC-TV18
Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company.
Bill Gates confers Indian Council of Medical Research "Lifetime Achievement Medal" on Dr. Cyrus Poonawalla
Dr. Cyrus Poonawalla conferred with 'Lifetime Achievement Award’ by the Asian Business Leadership Forum
Dr. Cyrus Poonawalla conferred with the prestigious honorary degree by the University of Oxford, U.K.